Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation-Reference-Cited by-同舟云学术

Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation

Published:2008-09-12 Issue:14 Volume:22 Page:1719-1728
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Falutz Julian,Allas Soraya,Mamputu Jean-Claude,Potvin Diane,Kotler Donald,Somero Michael,Berger Daniel,Brown Stephen,Richmond Gary,Fessel Jeffrey,Turner Ralph,Grinspoon Steven

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference16 articles.

1. Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy;Mallon;AIDS,2003

2. Glucose metabolism, lipid and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides;Dube;AIDS,2005

3. Cardiovascular risk and body fat abnormalities in HIV-infected adults;Grinspoon;N Engl J Med,2005

4. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with HIV disease;Triant;J Clin Endocrinol Metab,2007

5. Combination antiretroviral therapy and the risk of myocardial infarction;Friis-Moller;N Engl J Med,2003

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors;AIDS;2024-06-20

2. Dietary regimens appear to possess significant effects on the development of combined antiretroviral therapy (cART)-associated metabolic syndrome;PLOS ONE;2024-02-28

3. Modifications of the GH Axis Reveal Unique Sexually Dimorphic Liver Signatures for Lcn13, Asns, Hamp2, Hao2, and Pgc1a;Journal of the Endocrine Society;2024-01-16

4. Impact of HIV on the Hypothalamic-Pituitary Hormonal Axis;Pituitary Disorders throughout the Life Cycle;2022

5. Nuclear hormone and peptide hormone therapeutics for NAFLD and NASH;Molecular Metabolism;2021-04